Camallergy develops and provides new treatments for common food allergies.
Camallergy has raised $264K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in December 2023.
Camallergy's investors include Crowdcube, Innovate UK, Jonathan Milne.
Camallergy is headquartered in London, United Kingdom.
Camallergy develops and provides new treatments for common food allergies.
Camallergy is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Camallergy — Funding & Investors." VCBacked, December 11, 2023, https://www.vcbacked.co/company/camallergy. Accessed October 1, 2026.
VCBacked. (2023). Camallergy — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/camallergy
{{cite web |title=Camallergy — Funding & Investors |url=https://www.vcbacked.co/company/camallergy |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated